NCT06299462View on ClinicalTrials.gov

PTCy and ATG for MSD and MUD Transplants

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

June 1, 2031

Study Completion Date

June 1, 2031

Conditions
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromesHodgkin LymphomaNon-hodgkin Lymphoma
Interventions
DRUG

ATG 5.0

ATG 2.5 mg/kg on days -3 and -2

DRUG

Cyclophosphamide injection

Cyclophosphamide 50 mg/kg on days +3 and +4

DRUG

ATG 4.0

ATG 2.5 mg/kg on day -2 + 1.5 mg/kg on day -3

Trial Locations (1)

20230-130

RECRUITING

Instituto Nacional de Cancer, Rio de Janeiro

All Listed Sponsors
lead

Instituto Nacional de Cancer, Brazil

OTHER_GOV